Want to join the conversation?
$STJ 2Q15 Call: Sales for pacemakers for the second quarter totaled $249MM, up 1% from last year's second quarter on a constant currency basis. In the United States, pacemaker sales were $105MM. In International markets, pacemaker sales were $144MM, which included $23MM of unfavorable foreign currency translations.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.